Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Lipodystrophies
ADR ID BADD_A02556
ADR Hierarchy
23      Skin and subcutaneous tissue disorders
23.07      Skin and subcutaneous tissue disorders NEC
23.07.01      Lipodystrophies
Description A collection of heterogenous conditions resulting from defective LIPID METABOLISM and characterized by ADIPOSE TISSUE atrophy. Often there is redistribution of body fat resulting in peripheral fat wasting and central adiposity. They include generalized, localized, congenital, and acquired lipodystrophy. [MeSH]
MedDRA Code 10024606
MeSH ID D008060
ADR Severity Grade (FAERS) Not Available
ADR Severity Grade (CTCAE)
Synonym
Lipodystrophy | Lipodystrophies
ADR Related Proteins
Protein Name UniProt AC TTD Target ID
Cellular retinoic acid-binding protein 1P29762Not Available
Cytochrome P450 3A43Q9HB55Not Available
Low-density lipoprotein receptor-related protein 11Q86VZ4Not Available
Peroxisome proliferator-activated receptor gammaP37231T58921
Retinoic acid receptor RXR-alphaP19793T13726
Drugs Leading to the ADR
Drug IDDrug Name
BADD_D01358Mecasermin
BADD_D01366Medroxyprogesterone acetate
BADD_D01401Metformin
BADD_D01550Nelfinavir mesylate
BADD_D01557Nevirapine
BADD_D01699Pegvisomant
BADD_D01834Prednisone
BADD_D01906Raltegravir potassium
BADD_D01909Ramipril
BADD_D01933Ribavirin
BADD_D01940Rilpivirine
BADD_D01952Ritonavir
BADD_D01971Rosuvastatin
BADD_D01989Saquinavir mesylate
BADD_D02068Stavudine
BADD_D02098Sumatriptan
BADD_D02154Tenofovir
BADD_D02155Tenofovir disoproxil
BADD_D02156Tenofovir disoproxil fumarate
BADD_D02226Tipranavir
BADD_D02227Tipranavir disodium
BADD_D02383Zidovudine
BADD_D02438Enoxaparin
The 2th Page    First    Pre   2    Total 2 Pages